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INTRODUCTION
Prostate cancer is the second-leading cause of cancer death in men after lung cancer, with an estimated 33720 related deaths reported in 2011. 1 Prostate cancer accounted for 240890 (29%) of all newly diagnosed cases of cancer, making it the commonest internal malignancy in the United States in 2011. 1 Screening for prostate cancer had resulted in a stage migration of the disease, allowing cancers to be diagnosed and treated earlier with improved cancer specific survival. Indeed, mortality rates from prostate cancer continued to fall over the years since 1990. 1 Screening for prostate cancer currently involves serum prostate specific antigen (PSA) and digital rectal examination (DRE). However, the sensitivities and specificities of these screening tools, either alone or in combination, are low.
The optimal method of screening for prostate cancer has yet to be established.
therapy or prostate-related surgery were excluded from the study. Patients with clinically insignificant small cancer (tumour volume <0.5 mL) were also excluded from the study. We used C-500 sensor (Tactarray, Los Angels, CA, USA) as our robotic palpation module.
Experimental setup
In order to simulate rectal examination, a 3-dimensional model comprising of morphology of the bones and ligaments around the prostate was constructed. An artificial bony pelvis was also created with a 3-dimensional printer (rapid prototype) and the prostatic specimen was placed into its 'anatomical' position ( Fig. 1) . A DRE simulator model (MK-2, Limbs and things, Savannah, GA, USA) and two rotary encoders (E20s, Autonics, Bucheon, Gyeonggi, Korea) were utilized to measure the angle of yaw and pitch direction. The investigator who carried out the experiments was blinded to all clinical information.
Data acquisition
We used our robotic system to perform the palpation examination for localization of abnormal regions in 5 prostate glands. This was done in 5 sequential steps. Firstly, the tip of the probe was positioned in contact with the posterior surface of the prostate. Secondly, the prostatic tissue was indented with another 2 mm diameter probe at a rate of 1 mm/second to produce a 3 mm deep deformation in the tissue. Thirdly, when the deformation was induced, a reaction force occurred. This reaction force from the indented tissue was then measured by a force sensor in the fourth step. Finally, the reaction force and deformation data were acquired via a data acquisition system. All experiments were performed in the operating room within 30 minutes of extraction of the specimen. For each prostate specimen, the indentations were performed at a pre-determined 12 sites across the posterior surface of the prostate as shown in Fig. 2 . These 12 sites were similar to those of double-sextant needle biopsies, including the lateral apex, lateral-mid, lateral base, medial apex, medial mid, and medial base. A total of 60 indentations were performed on the 5 specimens.
Data processing and analysis
The finite element method (FEM) simulation was performed using the commercial software ABAQUS/Standard 6.5.1 (SIMULIA, Providence, RI, USA). The estimated elastic moduli were compared with the local normal criteria in order to diagnose and localize prostate cancer. 8 The local re-DRE is neither objective nor quantitative in screening for cancer. Physicians perform DRE by inserting a lubricated, gloved finger into the rectum of patients, feeling for areas suspicious for malignancy. Although DRE can be easily performed at consultation and has almost no risks, the findings are highly subjective and dependent of the physician's experience and expertise. Abnormal DRE had been shown to be an independent predictor of high-grade 2 and clinically significant tumors. 3, 4 However, various authors have reported dismal positive predictive value (PPV) of DRE, ranging from 28.0%
5 to 33%. 6 Technological advancement had led to mechanical systems providing tactile and kinesthetic feedback to the operator. 7 Ahn, et al. 8 reported differences in the mean elastic modulus of regions containing cancer and normal prostate tissues, using a motorized indenter in ex vivo experiments. They showed that the elastic modulus was quantitatively greater in tissues with a Gleason score of 8 or with a tumor volume >5 cm 3 when compared with normal tissues. It has been shown that the suspicious areas on magnetic resonance imaging (MRI) scans correlate well with location of malignant lesions in post-radical prostatectomy pathological specimens. 7, 9 In our present study, we aim to evaluate the correlation of the tissue mapping from our robotic indentation system with suspicious areas suggestive of malignancy on MRI scans. 5% (36/737) and 4% (4/94), respectively. After taking into account the prostate volume in prostate cancer detection, 9 Remzi, et al. 9 proposed an optimal number of biopsy cores, based on the age of patients and the total prostate volume in patients with a PSA of 2 to 10 ng/mL. Despite a protocolbased systemic biopsies, their overall prostate cancer detection rate was only 36.7%.
MATERIALS AND METHODS
Changes in the tissue elasticity may aid the identification of malignant cells as the cell integrity, and the intercellular matrix are pathologically changed in malignant transformation. Many measurements using mechanical devices have been performed to evaluate the properties of biological tissue using various techniques such as compressive pressure, 11 indentation, 12 aspiration, 13 and shear strain. These measurements allow any change in tissue behavior and biology to be objectively and quantitatively measured.
Previous in vitro studies had been conducted to demonstrate the 'stiffness' in cancer tissue with dynamic indentation and showed differences in the elastic modulus of cancer tissues from normal ones. To 'visualize' tissue elasticity, ultrasound real-time elastography has been utilized in clinics. However, this colored visualization of elasticity is not an obaction force was measured and the tissue's local elastic modulus was then estimated using the prostate model. Local normal criteria referred to the range between the upper bound (average+standard deviation) and the lower bound (average value-standard deviation) values. Localisation of any prostatic lesion was performed by comparing the estimated local elastic modulus and the normal tissue criteria, and a tissue mapping was obtained. We then compared the tissue mapping with suspicious areas of malignancies on MRI scans. A clinical radiologist, blinded to all relevant information, reported on suspicious malignant lesions on the MRI according to the 12 areas measured by the robotic system, as described earlier.
RESULTS
A total of 5 prostate specimens were analyzed. The mean age of the patients was 59.4±3.5 years (range 51-70 years), and the mean PSA level was 11.9±8.6 ng/mL (range, 4.9-22.6 ng/mL). The mean preoperative volume of the prostate was 26.3±8.3 mL (range, 18.3-39.4 mL). The pathologic tumor stage was T2c in 1 patient, T3a in 2 patients, and T3b in 2 patients.
Ex vivo experiments were performed for the 5 resected human prostate specimens. Overall, the mechanical properties of 60 regions from 5 prostate specimens were calculated from the FEM-based mechanical property characterization. As shown in Table 1 , the locations of the suspected malignant lesions in each specimen were correlated with the MRI scans.
Statistical analysis was performed. The concordance rate between the robotic system tissue mapping and MRI scan results was 90.0% (54/60). The sensitivity and specificity of our robotic indentation system were 87.9% (29/33) and 92.6% (25/27), respectively. The PPV and negative predictive value were 93.5% (29/31) and 93.1% (27/29), respectively.
DISCUSSION
In recent years, extended or saturation biopsies have been performed in attempts to improve prostate cancer detection rates over systemic sextant biopsy. 9 Djavan, et al. 10 performed a prospective study on the pathologic cancer detection rates of first, second, third, and fourth biopsies, and found that the cancer detection rates were 22% (231/1051), 10% (83/820), unparalleled ability to depict details of the prostate, due to its exquisite soft-tissue contrast. 15 Preliminary evidence suggests that MRI directed transrectal ultrasonography-guided biopsies may improve cancer detection rates. 16 Stoianovici, et al. 17 presented a fully automated MRI compatible "stealth" robot which can perform prostate biopsy and radioactive seed implantation for brachytherapy.
Current modalities in screening and diagnosis of prostate cancer are still sub-optimal due to low sensitivities and specificities. Therefore, more specific and sensitive advanced diagnostic tools will go a long way in the diagnosis and treatment of this common cancer. Our robotic system may have a role in achieving a more accurate guided biopsy and delivery of focal therapy to malignant lesions. jective and quantitative measurement. In addition, the compressive strength is not constant as this procedure is done free-handed and this makes objective comparisons difficult, if not impossible. In a previous study, elasticity mapping of normal tissue and cancer tissue were developed with the numerical function and the nonlinear surface fitting method. 8 This map served as our criteria for the diagnosis and localization of prostate cancer.
Our mechanical tissue mapping provides a quantitative and objective measure of suspected malignant lesions. With our robotic system, physicians can obtain objective mechanical and biological information about the suspected lesion, and perform more targeted prostatic biopsies as compared to DRE alone. The optimal number of needle biopsies during prostatic biopsies remains controversial.
14 Transrectal ultrasonography (TRUS) guided systemic needle biopsy is associated with significant adverse effects, and many physicians have argued about the appropriate number of biopsy cores necessary for cancer detection. In addition, due to the technical limitations of TRUS guided biopsy, even experienced urologists may perform inaccurate biopsies of a targeted area. Our robotic system may serve as an useful adjunct in the screening for prostate cancer. As DRE findings are subjective and physician-dependent, this could lead to imprecise exchange of important clinical history and information between physicians.
To validate the accuracy of our robotic indentation system, we compared our mechanical tissue mapping with MRI scans. Suspected malignant lesions on the tissue mapping closely corresponded to those seen on MRI scans. We believe that our robotic system will be a very useful and novel adjunct when translated to clinical practice. Being an ex vivo study, this comes with the usual associated limitations. Ideally, we should have cross validated our tissue mapping with actual pathological location of malignant areas on histology. However, our institution pathologists do not routinely provide the precise (12 areas) information which we needed for this study. In addition, the geometry of the human prostate is not flat or smooth; one other limitation of our study will be that the forces applied and the reaction force will not be uniformly constant throughout the specimen, limiting the achievement of ideal results. However, we recreated a 3D model of the human pelvis with artificial bones and ligaments in an attempt to simulate the in vitro conditions as closely as possible.
Of all noninvasive anatomic imaging modalities, MR imaging is most suitable for evaluating the prostate, as it has an
